OBJECTIVE: To investigate fetal or neonatal inflammatory patterns based on 25 inflammatory markers in neonatal dried blood spots samples from infants born preterm and term, collected several days after birth. METHODS: Dried blood spots samples from 160 neonates were analyzed for 25 inflammatory markers using multiplex technology: 26 neonates born very preterm (before 32 weeks of gestation), drawn at a mean 6 days (95% confidence interval [CI], 5-7 days) after birth; 52 born preterm (32-36 weeks of gestation), drawn at mean 5 days (95% CI, 5-6 days) after birth; and 82 born at term (at or after 37 weeks of gestation), drawn at mean 5 days (95% CI, 5-5 days) after birth. Markers statistically significantly associated with preterm birth were analyzed in a multivariable model together with maternal and neonatal risk factors for preterm birth. RESULTS: Elevated levels of interleukin (IL)-1beta, IL-6, soluble IL-6ralpha, IL-8, matrix metalloproteinase-9, and transforming growth factor-beta1 and decreased levels of IL-18, brain-derived neurotrophic factor, and C-reactive protein were associated with preterm birth. Maternal risk factors could explain only an increase of IL-1beta, whereas neonatal factors could explain several of the elevated and decreased inflammatory markers in the dried blood spots samples from the infants born preterm compared with the infants born at term. CONCLUSION: The differences in levels of inflammatory markers in dried blood spots samples from infants born preterm compared with infants born at term supports the hypothesis that inflammation of fetal origin might be a cause of preterm birth. LEVEL OF EVIDENCE: II.
OBJECTIVE: To investigate fetal or neonatal inflammatory patterns based on 25 inflammatory markers in neonatal dried blood spots samples from infants born preterm and term, collected several days after birth. METHODS: Dried blood spots samples from 160 neonates were analyzed for 25 inflammatory markers using multiplex technology: 26 neonates born very preterm (before 32 weeks of gestation), drawn at a mean 6 days (95% confidence interval [CI], 5-7 days) after birth; 52 born preterm (32-36 weeks of gestation), drawn at mean 5 days (95% CI, 5-6 days) after birth; and 82 born at term (at or after 37 weeks of gestation), drawn at mean 5 days (95% CI, 5-5 days) after birth. Markers statistically significantly associated with preterm birth were analyzed in a multivariable model together with maternal and neonatal risk factors for preterm birth. RESULTS: Elevated levels of interleukin (IL)-1beta, IL-6, soluble IL-6ralpha, IL-8, matrix metalloproteinase-9, and transforming growth factor-beta1 and decreased levels of IL-18, brain-derived neurotrophic factor, and C-reactive protein were associated with preterm birth. Maternal risk factors could explain only an increase of IL-1beta, whereas neonatal factors could explain several of the elevated and decreased inflammatory markers in the dried blood spots samples from the infants born preterm compared with the infants born at term. CONCLUSION: The differences in levels of inflammatory markers in dried blood spots samples from infants born preterm compared with infants born at term supports the hypothesis that inflammation of fetal origin might be a cause of preterm birth. LEVEL OF EVIDENCE: II.
Authors: Nina R Morrison; Stephen M Johnson; Austin D Hocker; Rebecca S Kimyon; Jyoti J Watters; Adrianne G Huxtable Journal: Respir Physiol Neurobiol Date: 2019-10-12 Impact factor: 1.931
Authors: Stephen M Johnson; Karanbir S Randhawa; Jenna J Epstein; Ellen Gustafson; Austin D Hocker; Adrianne G Huxtable; Tracy L Baker; Jyoti J Watters Journal: Respir Physiol Neurobiol Date: 2017-11-22 Impact factor: 1.931
Authors: Paula Krakowiak; Paula E Goines; Daniel J Tancredi; Paul Ashwood; Robin L Hansen; Irva Hertz-Picciotto; Judy Van de Water Journal: Biol Psychiatry Date: 2015-08-14 Impact factor: 13.382
Authors: L Marcela Merchan; Hazem E Hassan; Michael L Terrin; Ken B Waites; David A Kaufman; Namasivayam Ambalavanan; Pamela Donohue; Susan J Dulkerian; Robert Schelonka; Laurence S Magder; Sagar Shukla; Natalie D Eddington; Rose M Viscardi Journal: Antimicrob Agents Chemother Date: 2014-11-10 Impact factor: 5.191
Authors: Emily A McDonald; Ling Cheng; Blanca Jarilla; Marianne J Sagliba; Annaliza Gonzal; Amabelle J Amoylen; Remigio Olveda; Luz Acosta; David Baylink; Eric S White; Jennifer F Friedman; Jonathan D Kurtis Journal: Infect Immun Date: 2013-10-28 Impact factor: 3.441